文献速递脑血管病

卒中机械取栓患者选择中先进神经影像的应用

Advanced Neuroimaging in Stroke Patient Selection for Mechanical Thrombectomy.
PubMed 文献 · Stroke · 2018-01-01

该系统综述与荟萃分析纳入10项随机临床试验共2227例患者,间接比较先进神经影像与传统影像选择机械取栓患者的效果。先进影像组3个月功能独立、良好功能结局和功能改善的效应量均更高,成功再灌注率更高,死亡和症状性颅内出血无差异。

要点

  • 先进神经影像选择与取栓后3个月功能独立OR 3.79(95%CI 2.71-5.28)相关。
  • 先进影像组成功再灌注率更高,死亡和症状性颅内出血无差异。
  • 先进神经影像用于选择与预后判断不应依赖症状发作时间。

核心结论

  • 间接比较提示先进神经影像选择急性缺血性卒中机械取栓患者与临床结局改善相关。

研究设计与样本

  • 系统综述与荟萃分析,纳入10项随机临床试验,共2227例患者,平均年龄67岁。

主要发现

  • 先进影像组3个月功能独立OR 3.79(95%CI 2.71-5.28),传统影像组OR 1.89(95%CI 1.52-2.35),亚组差异P<0.001。
  • 先进影像组良好功能结局OR 3.16(95%CI 1.94-5.14),传统影像组OR 1.75(95%CI 1.30-2.34),亚组差异P=0.04。
  • 先进影像组功能改善common OR 2.66(95%CI 1.95-3.63),传统影像组common OR 1.60(95%CI 1.32-1.95),亚组差异P=0.007。
  • 先进影像组取栓后成功再灌注的合并率更高,亚组差异P=0.003。
  • 两组死亡率和症状性颅内出血率无差异,所有分析无 heterogeneity 证据。

临床怎么用

  • 先进神经影像可用于机械取栓患者选择和预后预测,且不应依赖症状发作至治疗时间。

局限性

  • 结论基于间接比较,非直接头对头随机对照证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- There is clinical equipoise about the use of advanced imaging for selecting acute ischemic stroke patients eligible for mechanical thrombectomy (MT) during the first 6 hours from symptom onset. However, accumulating evidence indicates that advanced neuroimaging represents an invaluable and time-independent prognostic factor. Methods- We performed a systematic review and meta-analysis of available randomized clinical trials to evaluate the impact of patient selection with advanced neuroimaging on the 3-month: (1) functional independence (modified Rankin Scale score, 0-2), (2) favorable functional outcome (modified Rankin Scale scores, 0-1), (3) all-cause mortality, and (4) functional improvement (assessed with ordinal analysis of the modified Rankin Scale-scores). We compared patients with perfusion imaging documented penumbra to patients who did not have documented penumbra or perfusion imaging. Results- Among the 10 eligible randomized clinical trials (2227 total patients, mean age: 67 years), 5 studies reported the use of advanced imaging. Studies using advanced neuroimaging showed higher treatment effects of MT on 3-month functional independence (odds ratio [OR], 3.79; 95% CI, 2.71-5.28 versus OR, 1.89; 95% CI, 1.52-2.35; P for subgroup differences <0.001), favorable functional outcome (OR, 3.16; 95% CI, 1.94-5.14 versus OR, 1.75; 95% CI, 1.30-2.34; P for subgroup differences=0.04), and functional improvement (common OR, 2.66; 95% CI, 1.95-3.63 versus common OR, 1.60; 95% CI, 1.32-1.95; P for subgroup differences=0.007) compared with studies using conventional neuroimaging. The pooled rate of successful reperfusion after MT was higher in studies with advanced neuroimaging ( P for subgroup differences=0.003). No difference in the mortality and symptomatic intracranial hemorrhage rates was found between the 2 groups. No evidence of heterogeneity was documented in all reported analyses. Conclusions- The present indirect comparisons indicate that acute ischemic stroke patient selection for MT using advanced neuroimaging appears to be associated with improved clinical outcomes. The use of advanced neuroimaging for both the selection and prediction of prognosis for MT candidates should not depend on the elapsed time from symptom onset.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tsivgoulis G, Katsanos AH, Schellinger PD, et al. Advanced Neuroimaging in Stroke Patient Selection for Mechanical Thrombectomy. Stroke. 2018. PMID: 30571421. doi:10.1161/STROKEAHA.118.022540

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。